Purchases and Sales Made in Q3 2022 in Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX) during Q3 2022. The information is specifically focused on institutions that hold shares of Vaxcyte, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-23.5K- 99.68% |
$510K - $670K
|
75
$6.3K
|
|
Nov 14, 2022
Q3 2022
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-25.1K- 3.47% |
$545K - $717K
|
699K
$58.7M
|
|
Nov 14, 2022
Q3 2022
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-35K- 9.44% |
$759K - $999K
|
336K
$28.2M
|
|
Nov 10, 2022
Q3 2022
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
SELL
|
- |
-56.1K- 6.74% |
$1.22M - $1.6M
|
776K
$65.2M
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-95.1K- 69.11% |
$2.06M - $2.71M
|
42.5K
$3.57M
|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-104K- 63.67% |
$2.25M - $2.96M
|
59.3K
$4.98M
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-170K- 16.96% |
$3.69M - $4.85M
|
833K
$70M
|
|
Nov 14, 2022
Q3 2022
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-240K- 13.43% |
$5.21M - $6.85M
|
1.55M
$130M
|
|
Nov 14, 2022
Q3 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-270K- 57.88% |
$5.85M - $7.7M
|
196K
$16.5M
|
|
Feb 07, 2025
Q3 2022
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-273K- 92.99% |
$5.93M - $7.8M
|
20.6K
$1.73M
|
|
Nov 14, 2022
Q3 2022
|
Tpg Gp A, LLC
Fort Worth, TX |
SELL
|
- |
-382K- 10.41% |
$8.28M - $10.9M
|
3.29M
$276M
|
|
Nov 14, 2022
Q3 2022
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-385K- 39.1% |
$8.35M - $11M
|
600K
$50.4M
|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-796K- 52.57% |
$17.3M - $22.7M
|
718K
$60.3M
|